According to the warning letter, Medtronic failed to correct a flaw in its SynchroMed II infusion pump and properly document and investigate more than 560 complaints about the device.
Medtronic is working to resolve the complaints and implement corrective action to improve its investigative process, according to a company spokeswoman.
More Articles on Devices:
TransCorp Spine Granted U.S. Patent for SpinePort MIS Access System
Wright Medical Group Announces $200M in Senior Notes
Globus Medical 2Q Sales Climb 18.6% to $96M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
